{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:57:11Z","timestamp":1780545431112,"version":"3.54.1"},"posted":{"date-parts":[[2024,9,29]]},"group-title":"Immunology","reference-count":49,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Chimeric antigen receptor T cell (CART) therapy has seen great clinical success. However, up to 50% of leukemia patients relapse and long-term survivor data indicate that CART cell persistence is key to enforcing relapse-free survival. Unfortunately, ex vivo expansion protocols often drive metabolic and functional exhaustion, reducing in vivo efficacy. Preclinical models have demonstrated that redirecting metabolism ex vivo can improve in vivo T cell function and we hypothesized that exposure to an agonist targeting the metabolic regulator AMP-activated protein kinase (AMPK), would create CARTs capable of both efficient leukemia clearance and increased in vivo persistence.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>CART cells were generated from healthy human via lentiviral transduction. Following activation, cells were exposed to either Compound 991 or DMSO for 96 hours, followed by a 48-hour washout. During and after agonist treatment, T cells were harvested for metabolic and functional assessments. To test in vivo efficacy, immunodeficient mice were injected with luciferase+ NALM6 leukemia cells, followed one week later by either 991- or DMSO-expanded CARTs. Leukemia burden and anti-leukemia efficacy was assessed via radiance imaging and overall survival.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Human T cells expanded in Compound 991 activated AMPK without limiting cellular expansion and gained both mitochondrial density and improved handling of reactive oxygen species (ROS). Importantly, receipt of 991-exposed CARTs significantly improved in vivo leukemia clearance, prolonged recipient survival, and increased CD4+ T cell yields at early times post-injection. Ex vivo, 991 agonist treatment mimicked nutrient starvation, increased autophagic flux, and promoted generation of mitochondrially-protective metabolites.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>DISCUSSION<\/jats:title>\n                  <jats:p>Ex vivo expansion processes are necessary to generate sufficient cell numbers, but often promote sustained activation and differentiation, negatively impacting in vivo persistence and function. Here, we demonstrate that promoting AMPK activity during CART expansion metabolically reprograms cells without limiting T cell yield, enhances in vivo anti-leukemia efficacy, and improves CD4+ in vivo persistence. Importantly, AMPK agonism achieves these results without further modifying the expansion media, changing the CART construct, or genetically altering the cells. Altogether, these data highlight AMPK agonism as a potent and readily translatable approach to improve the metabolic profile and overall efficacy of cancer-targeting T cells.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.09.26.615290","type":"posted-content","created":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T19:30:21Z","timestamp":1727638221000},"source":"Crossref","is-referenced-by-count":2,"title":["AMPK agonism optimizes the\n                  <i>in vivo<\/i>\n                  persistence and anti-leukemia efficacy of chimeric antigen receptor T cells"],"prefix":"10.64898","author":[{"given":"Erica L","family":"Braverman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Ramgopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Mullet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C","family":"Poholek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy L","family":"Gelhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Byersdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2024100312500841000_2024.09.26.615290v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"2024100312500841000_2024.09.26.615290v1.2","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/j.clml.2020.12.010","article-title":"Systematic Review and Meta-analysis of CD19-Specific CAR-T Cell Therapy in Relapsed\/Refractory Acute Lymphoblastic Leukemia in the Pediatric and Young Adult Population: Safety and Efficacy Outcomes","volume":"21","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2024100312500841000_2024.09.26.615290v1.3","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.22.00642","article-title":"Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed\/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial","volume":"41","year":"2023","journal-title":"J Clin Oncol"},{"key":"2024100312500841000_2024.09.26.615290v1.4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69589"},{"key":"2024100312500841000_2024.09.26.615290v1.5","first-page":"10011","article-title":"STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed\/refractory solid tumors","volume":"40 16_suppl","year":"2022","journal-title":"JCO"},{"key":"2024100312500841000_2024.09.26.615290v1.6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-024-07300-8","article-title":"FOXO1 is a master regulator of memory programming in CAR T cells","volume":"629","year":"2024","journal-title":"Nature"},{"key":"2024100312500841000_2024.09.26.615290v1.7","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/eji.201948455","article-title":"Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells","volume":"50","year":"2020","journal-title":"Eur J Immunol"},{"key":"2024100312500841000_2024.09.26.615290v1.8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/0008-5472.CAN-23-0801","article-title":"Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3K\u03b4 Blockade Improves Metabolism and Antitumor Immunity","volume":"84","year":"2024","journal-title":"Cancer Res"},{"key":"2024100312500841000_2024.09.26.615290v1.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0452"},{"key":"2024100312500841000_2024.09.26.615290v1.10","doi-asserted-by":"crossref","unstructured":"Klebanoff CA , Crompton JG , Leonardi AJ , Yamamoto TN , Chandran SS , Eil RL , et al. Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight. 2017;2.","DOI":"10.1172\/jci.insight.95103"},{"key":"2024100312500841000_2024.09.26.615290v1.11","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0466"},{"key":"2024100312500841000_2024.09.26.615290v1.12","doi-asserted-by":"crossref","unstructured":"Lontos K , Wang Y , Joshi SK , Frisch AT , Watson MJ , Kumar A , et al. Metabolic reprogramming via an engineered PGC-1\u03b1 improves human chimeric antigen receptor T-cell therapy against solid tumors. J Immunother Cancer. 2023;11.","DOI":"10.1136\/jitc-2022-006522"},{"key":"2024100312500841000_2024.09.26.615290v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.035"},{"key":"2024100312500841000_2024.09.26.615290v1.14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","article-title":"Enforced PGC-1\u03b1 expression promotes CD8 T cell fitness, memory formation and antitumor immunity","volume":"18","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2024100312500841000_2024.09.26.615290v1.15","doi-asserted-by":"crossref","first-page":"215710","DOI":"10.1016\/j.canlet.2022.215710","article-title":"Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity","volume":"538","year":"2022","journal-title":"Cancer Lett"},{"key":"2024100312500841000_2024.09.26.615290v1.16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s42255-023-00856-1","article-title":"Asparagine restriction enhances CD8+ T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response","volume":"5","year":"2023","journal-title":"Nat Metab"},{"key":"2024100312500841000_2024.09.26.615290v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.09.031"},{"key":"2024100312500841000_2024.09.26.615290v1.18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s42255-020-0219-4","article-title":"Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction","volume":"2","year":"2020","journal-title":"Nat Metab"},{"key":"2024100312500841000_2024.09.26.615290v1.19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.mie.2019.08.016","article-title":"Generating stem-like memory T cells with antioxidants for adoptive cell transfer immunotherapy of cancer","volume":"631","year":"2020","journal-title":"Meth Enzymol"},{"key":"2024100312500841000_2024.09.26.615290v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.09.013"},{"key":"2024100312500841000_2024.09.26.615290v1.21","doi-asserted-by":"crossref","first-page":"105488","DOI":"10.1016\/j.jbc.2023.105488","article-title":"Overexpression of AMPK\u03b32 increases AMPK signaling to augment human T cell metabolism and function","volume":"300","year":"2024","journal-title":"J Biol Chem"},{"key":"2024100312500841000_2024.09.26.615290v1.22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1920413117"},{"key":"2024100312500841000_2024.09.26.615290v1.23","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00237.2016"},{"key":"2024100312500841000_2024.09.26.615290v1.24","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20170458"},{"key":"2024100312500841000_2024.09.26.615290v1.25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s42255-020-0245-2","article-title":"Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK \u03b21 isoforms","volume":"2","year":"2020","journal-title":"Nat Metab"},{"key":"2024100312500841000_2024.09.26.615290v1.26","doi-asserted-by":"crossref","first-page":"113738","DOI":"10.1016\/j.celrep.2024.113738","article-title":"Proline restores mitochondrial function and reverses aging hallmarks in senescent cells","volume":"43","year":"2024","journal-title":"Cell Rep"},{"key":"2024100312500841000_2024.09.26.615290v1.27","first-page":"4628962","article-title":"Glycine suppresses AGE\/RAGE signaling pathway and subsequent oxidative stress by restoring glo1 function in the aorta of diabetic rats and in huvecs","volume":"2019","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"2024100312500841000_2024.09.26.615290v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2007.10.054"},{"key":"2024100312500841000_2024.09.26.615290v1.29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.biopha.2017.10.166","article-title":"Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice","volume":"97","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"2024100312500841000_2024.09.26.615290v1.30","doi-asserted-by":"crossref","first-page":"e2200109","DOI":"10.1002\/mnfr.202200109","article-title":"Branched-Chain Amino Acids and Mitochondrial Biogenesis: An Overview and Mechanistic Summary","volume":"66","year":"2022","journal-title":"Mol Nutr Food Res"},{"key":"2024100312500841000_2024.09.26.615290v1.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001093"},{"key":"2024100312500841000_2024.09.26.615290v1.32","doi-asserted-by":"crossref","unstructured":"St Paul M , Saibil SD , Kates M , Han S , Lien SC , Laister RC , et al. Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy. Cell Rep Med. 2024;:101465.","DOI":"10.1016\/j.xcrm.2024.101465"},{"key":"2024100312500841000_2024.09.26.615290v1.33","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1080\/15548627.2023.2246356","article-title":"Lactate is a bridge linking glycolysis and autophagy through lactylation","volume":"19","year":"2023","journal-title":"Autophagy"},{"key":"2024100312500841000_2024.09.26.615290v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.03.003"},{"key":"2024100312500841000_2024.09.26.615290v1.35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093597"},{"key":"2024100312500841000_2024.09.26.615290v1.36","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0516"},{"key":"2024100312500841000_2024.09.26.615290v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.021"},{"key":"2024100312500841000_2024.09.26.615290v1.38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.omtm.2022.02.004","article-title":"Clinically relevant T cell expansion media activate distinct metabolic programs uncoupled from cellular function","volume":"24","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2024100312500841000_2024.09.26.615290v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.02"},{"key":"2024100312500841000_2024.09.26.615290v1.40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705070104"},{"key":"2024100312500841000_2024.09.26.615290v1.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003614"},{"key":"2024100312500841000_2024.09.26.615290v1.42","doi-asserted-by":"crossref","first-page":"101393","DOI":"10.1016\/j.redox.2019.101393","article-title":"AMPK leads to phosphorylation of the transcription factor Nrf2, tuning transactivation of selected target genes","volume":"29","year":"2020","journal-title":"Redox Biol"},{"key":"2024100312500841000_2024.09.26.615290v1.43","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00118-16"},{"key":"2024100312500841000_2024.09.26.615290v1.44","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1038\/s41598-020-78715-2","article-title":"Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species","volume":"10","year":"2020","journal-title":"Sci Rep"},{"key":"2024100312500841000_2024.09.26.615290v1.45","unstructured":"KEGG PATHWAY: Glycine, serine and threonine metabolism - Reference pathway. https:\/\/www.genome.jp\/pathway\/map00260. Accessed 3 Jun 2024."},{"key":"2024100312500841000_2024.09.26.615290v1.46","doi-asserted-by":"crossref","first-page":"eadj1431","DOI":"10.1126\/sciadv.adj1431","article-title":"13C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells","volume":"10","year":"2024","journal-title":"Sci Adv"},{"key":"2024100312500841000_2024.09.26.615290v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102838"},{"key":"2024100312500841000_2024.09.26.615290v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04390-6"},{"key":"2024100312500841000_2024.09.26.615290v1.49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.26.615290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:09:33Z","timestamp":1768460973000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.09.26.615290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,29]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1101\/2024.09.26.615290","relation":{},"subject":[],"published":{"date-parts":[[2024,9,29]]},"subtype":"preprint"}}